CG
Christopher Paul German
Corporate Controller & CAO

Christopher Paul German insider trades: Rhythm Pharmaceuticals (RYTM) stock sales

Corporate Controller & CAO, Rhythm Pharmaceuticals Last trade May 15, 2026 11 Form 4 filings
$931K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christopher reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 15, 2026RYTM↓ Sell$428K
Mar 4, 2026RYTM↓ Sell$503K
Aug 12, 2025RYTM↓ Sell$143K
Jul 9, 2025RYTM↓ Sell$308K
Jun 10, 2025RYTM↓ Sell$139K
Mar 21, 2025RYTM↓ Sell$19K
Feb 19, 2025RYTM↓ Sell$36K
Apr 2, 2024RYTM↓ Sell$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RYTM insiders

Open-market trades in the last 12 months

About Christopher Paul German's insider trades

Christopher Paul German is Corporate Controller & CAO at Rhythm Pharmaceuticals (RYTM). Since Apr 2, 2024, Christopher has reported no open-market purchases and 8 sales worth $1.6M on SEC Form 4. In the last 12 months: 2 sales ($931K).

Their filings also include option exercises (9 filings), grants and awards (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.